Street Calls of the Week
Codexis, Inc. (NASDAQ:CDXS) Chief Financial Officer Georgia Erbez sold 6,239 shares of common stock on October 13, 2025, at a price of $2.505, for a total transaction value of $15,628. The transaction comes as the $245 million market cap company trades at $2.74, with InvestingPro data showing notably volatile stock movements and weak financial health metrics.
Following the transaction, Erbez directly owns 70,636 shares of Codexis , including 33,333 restricted stock units. According to InvestingPro analysis, while the company maintains strong liquidity with a current ratio of 5.82, investors should note that Codexis is rapidly burning through cash. For deeper insights into Codexis’s financial health and 7 additional key ProTips, consider exploring the comprehensive Pro Research Report.
The sale was executed to cover tax obligations related to the vesting of restricted stock units, according to a footnote in the SEC filing. Investors tracking this development should mark their calendars for October 30, 2025, when Codexis is scheduled to report its next earnings.
In other recent news, Codexis, Inc. reported its second-quarter 2025 financial results, showing a revenue increase to $15.3 million, up from $8.0 million in the same period last year. The company also posted a reduced net loss of $13.3 million, or ($0.16) per share, compared to a net loss of $22.8 million, or ($0.32) per share, in the second quarter of 2024. Codexis surpassed analyst expectations with an earnings per share of -$0.16, beating the forecasted -$0.19. Stifel reiterated its Buy rating on Codexis, citing the company’s revenue beat and positive updates on its Pharma Biocatalysis business and ECO Synthesis Platform. Cantor Fitzgerald maintained its Overweight rating and $11 price target, highlighting Codexis’s strengthened balance sheet, which supports ongoing operational developments. Benchmark reiterated its Hold rating on the stock following the financial results. These updates reflect a robust business outlook for Codexis as it continues to make strides in its financial and operational performance.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.